Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUC-HEART: hUCS-MSCs in Myocardial Infarction
NCT02323477Phase 2Terminated
- Sponsor
- Ankara University
- Start
- Feb 2015
- Primary completion
- Sep 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of human umbilical cord stroma-derived multipotent stromal cells in ischemic cardiomyopathy (ICM) (3 arms), sponsored by Ankara University. Primary endpoint: Ventricular remodeling at 1 year. Started Feb 2015; status: terminated.
02
Drugs
human umbilical cord stroma-derived multipotent stromal cells
03
Conditions
ischemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on NCT02323477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323477.